2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Stomach Neoplasms
8
Barrett Esophagus
7
Gastritis
5
Breast Neoplasms
4
Stomach Ulcer
3
Peptic Ulcer
3
Gastroesophageal Reflux
3
Dyspepsia
3
Zollinger-Ellison Syndrome
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Vomiting
1
Radiation Esophagitis
1
Precancerous Conditions
1
Peptic Ulcer Hemorrhage
1
Neoplasms
1
Neoplasm Metastasis
1
Nausea
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Hot Flashes
1
Hemorrhage
1
Head and Neck Neoplasms
1
Gastrointestinal Stromal Tumors
1
Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer
1
Esophagitis, Peptic
1
Esophagitis
1
Dysbiosis
1
Drug-Related Side Effects and Adverse Reactions
1
Interventions
Dexamethasone
51
Aprepitant
39
Palonosetron
37
Ondansetron
31
Granisetron
22
Calcium Dobesilate
14
fosaprepitant
13
Olanzapine
13
Therapeutics
8
dexamethasone acetate
7
ramosetron
6
netupitant, palosentron drug combination
6
casopitant
6
Tropisetron
6
Cyclophosphamide
6
dexamethasone 21-phosphate
5
Radiotherapy
5
Metoclopramide
5
Doxorubicin
5
netupitant
4
dolasetron
4
Surveys and Questionnaires
4
Dronabinol
4
Acupressure
4
Yoga
3
Vincristine
3
Tablets
3
Psychiatric Rehabilitation
3
Prochlorperazine
3
Lorazepam
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Vomiting
×
Esomeprazole
×
Clear all
NCT00206440
2018-12-06
NEXIUM
Baylor Breast Care Center
Phase 3
Terminated
43 enrolled
5 charts